Owing to low shelf life and dip in demand, hundreds of millions of Covid-19 vaccines in India are looking to expire over the next three to four months. Vaccine industry sources indicated that shelf life extension has been sought from time to time as more stability data is generated.
Players like Bharat Biotech have been working pro-actively with private hospitals for the past few months to liquidate stocks. A company source said, “Bharat Biotech has been working proactively with private hospitals for the past several months to liquidate stocks and reduce the quantum of expired vaccines. We are replacing expired